Switched to a once per day 7% min, 0.15% fin product. Is this a good idea? I'm a week and a half in and second guessing myself. No side effects.
    Finasteride/Dutasteride 9/10/2024

    From the encyclopedia
    Minoxidil β†’

    Vasodilator used on the scalp and, at low doses, as a tablet

    Finasteride β†’

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    Azelaic Acid β†’

    Acid used in acne and rosacea creams

    At a glance
    In this question or advice post, the primary subjects mentioned are
    πŸ’§ Minoxidil (topical) 7% 1x daily 1.5 weeks
    πŸ’§ Finasteride (topical) 0.15% 1x daily 1.5 weeks
    πŸ’§ Azelaic acid (topical) 1.5% 1x daily 1.5 weeks
    πŸ’§ Adenosine, Biotin and Niacinamide (topical) 0.8% 1x daily 1.5 weeks
    πŸ’§ Retinoic Acid (topical) 0.025% 1x daily 1.5 weeks
    πŸ’§ Caffeine (topical) 0.001% 1x daily 1.5 weeks
    πŸ’§ RU58841 (topical) 1.25% 1x daily 1.5 weeks
    πŸ’§ derma stamp (topical) 1.5mm 1x weekly 1.5 weeks
    πŸ’§ Sent from Earth shampoo (topical) 2x weekly 1.5 weeks
    the tone is 😐 neutral with some growth results.

    Other terms

    A 59-year-old male switched to a once-daily treatment of 7% Minoxidil, 0.15% Finasteride, and other ingredients, questioning its effectiveness compared to his previous twice-daily regimen. He has seen some hair regrowth but is unsure if the new treatment is better.
    View this post in the Community β†’

    Similar Community Posts Join

    5 / 5 results

      community Exploring Bryan Johnson's Hair Routine In Detail

       64 upvotes 2 years ago
      Bryan Johnson uses a custom hair loss treatment that includes topical finasteride, minoxidil, azelaic acid, diclofenac, tea tree oil, rosemary oil, ginkgo biloba, biotin, and melatonin, which have shown varying degrees of effectiveness with minimal side effects. He also undergoes PRP and laser therapy, and has tried dutasteride mesotherapy.

      community Topical solution recommendation

      in Treatment  2 upvotes 1 year ago
      The user is using finasteride 1mg every other day and seeks a topical solution excluding minoxidil. They are considering various combinations of ingredients like finasteride, dutasteride, and tofacitinib, with options for nourishing oils and other additives.

      community Topical solution recommendation

      in Product  1 upvotes 1 year ago
      The user is using finasteride 1mg every other day and seeks a topical solution to complement it, excluding minoxidil. They are considering various combinations of ingredients like finasteride, dutasteride, and tofacitinib, with options for nourishing oils and other additives.

    Related Research

    6 / 6 results

      research Mesococktails and mesoproducts in aesthetic dermatology

      11 citations , August 2020 in “Dermatologic therapy”
      This review article highlights that mesotherapy, a popular non-surgical procedure in aesthetic dermatology, involves injecting a mixture of compounds into the skin for purposes like skin rejuvenation and hair loss treatment, but lacks large-scale studies on its efficacy and safety.

      research Androgenetic Alopecia: Overview

      3 citations , November 1999 in “Journal of Cutaneous Medicine and Surgery”
      AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

      research Androgenetic Alopecia: An Evidence-Based Treatment Update

      151 citations , May 2014 in “American Journal of Clinical Dermatology”
      This review concluded that oral finasteride for men and topical minoxidil for both genders have the most evidence supporting their effectiveness and safety for treating androgenetic alopecia.

      research Novel agents for the treatment of alopecia

      29 citations , December 1998 in “Seminars in Cutaneous Medicine and Surgery”
      This review examines recent approvals and emerging treatments for androgenetic alopecia, discussing newly approved drugs like Propecia and Rogaine Extra Strength 5%, but without presenting new clinical results.